Frontlight ResearchEarly access
Trial site
Odesa
- 2running trials
The trials here
What the 2 trials at this site are about, from their registry records.
- Conditions
- Multiple sclerosis2 trials
- Phase
- Phase 21 trial
- Phase 31 trial
- Status
- Active, not recruiting1 trial
- Recruiting1 trial
- Lead sponsor
- TG Therapeutics, Inc.2 trials
Running trials
Recruiting
Active, not recruiting
An Extension Study of Ublituximab in Participants With Relapsing Multiple Sclerosis
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Multiple sclerosis1 recruiting
Site data: ClinicalTrials.govUpdated 12 Nov 2026